L-Lactic Acid

L-Lactic Acid

SCHEMBL36963

CC(O)C(=O)[O-].C[N+](C)(C)C

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3

The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.44
SLC22A16 Q86VW1 1/20 0.40
BBOX1 O75936 2/20 0.39
CA1 P00915 4/20 0.35
CA4 P22748 2/20 0.35
CA2 P00918 1/20 0.35
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Lactic Acid SCHEMBL9305713 1.00 TP53 (0.44) TP53SLC22A16BBOX1CA1CA4
L-Lactic Acid SCHEMBL9312891 0.97 TP53 (0.42) TP53SLC22A16BBOX1CA1CA4
L-Lactic Acid SCHEMBL3820373 0.88 BBOX1 (0.41) TP53SLC22A16BBOX1CA1CA4
L-Lactic Acid SCHEMBL27503017 0.87
L-Lactic Acid SCHEMBL3767829 0.86 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL7515818 0.86 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL992199 0.86
L-Lactic Acid SCHEMBL21815670 0.86 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL22341771 0.86 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL152527 0.86 TP53 (0.50) TP53CA1CA4CA2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117658802-A Method for preparing lactate by catalyzing alcoholysis of polylactic acid by ionic liquid 中国科学院化学研究所 2024-03-08 CN claimed
CN-117658794-A Method for preparing lactic acid by catalyzing polylactic acid hydrolysis through ionic liquid 中国科学院化学研究所 2024-03-08 CN claimed
CN-117623968-A Method for preparing N-substituted lactamide by catalyzing polylactic acid aminolysis with ionic liquid 中国科学院化学研究所 2024-03-01 CN claimed
CN-110585860-A Low-energy-consumption regenerated absorbent and method for absorbing sulfur dioxide in flue gas by using same 太原师范学院 2019-12-20 CN claimed
CN-103079407-A Improved insecticidal compositions comprising cyclic carboximidamidines BAYER CROPSCIENCE AG 2013-05-01 CN claimed
US-20120004268-A1 INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES BAYER CROPSCIENCE AG (DE) 2012-01-05 US claimed
US-6277799-B1 AQUEOUS MIXTURE OF SALT OF HYDROXYCARBOXYLIC ACID AND SURFACTANTS INTERNATIONAL BUSINESS MACHINES CORPORATION 2001-08-21 US claimed
US-12594700-B2 Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes COVESTRO DEUTSCHLAND AG (DE) 2026-04-07 US disclosed
US-20250388778-A1 POLYISOCYANATE MIXTURE COVESTRO DEUTSCHLAND AG (DE) 2025-12-25 US disclosed
US-12492281-B2 Polyisocyanurate materials as electrical potting compounds COVESTRO DEUTSCHLAND AG (DE) 2025-12-09 US disclosed
CN-120118300-A Polycarbonate copolymer and preparation method and application thereof 华东理工大学 2025-06-10 CN disclosed
EP-4551634-A1 POLYISOCYANATE MIXTURE Covestro Deutschland AG (DE) 2025-05-14 EP disclosed
EP-3688050-B1 TWO-COMPONENT SYSTEM FOR ELASTIC COATINGS COVESTRO DEUTSCHLAND AG (DE) 2025-03-26 EP disclosed
EP-1033624-A1 RADIATION-SENSITIVE COMPOSITION OF CHEMICAL AMPLIFICATION TYPE Clariant International Ltd. (CH) 2000-09-06 EP disclosed
US-5576459-A Quaternary nitrogen or phosphorus chirates SACHEM, INC. (US) 1996-11-19 US disclosed
US-5371001-A Transesterification in the presence of carboxy-esterases or carboxyamidases E. I. DU PONT DE NEMOURS AND COMPANY (US) 1994-12-06 US disclosed
US-5326887-A Reacting ester of alpha hydroxy acid oligomer over fixed bed catalyst E. I. DU PONT DE NEMOURS AND COMPANY (US) 1994-07-05 US disclosed
US-5254718-A Using enzyme catalyst; simplified separation, purification E. I. DU PONT DE NEMOURS & COMPANY (US) 1993-10-19 US disclosed
WO-1992015572-A1 PROCESS FOR THE PREPARATION OF 1,4-DIOXANE-2,5-DIONES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-09-17 WO disclosed
WO-1992015547-A1 ESTERS OF UNSYMMETRICALLY 2-SUBSTITUTED GLYCOLIC ACID DIMERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388778-A1 POLYISOCYANATE MIXTURE IPO11, IPO5, ALKBH1 TP53 2565/4885SLC22A16 1412/4885BBOX1 1793/4885
US-12594700-B2 Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes TST, C9, ESD TP53 4587/4885SLC22A16 2401/4885BBOX1 1883/4885
US-20120004268-A1 INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES DDT, PRMT9, PNISR TP53 4746/4885SLC22A16 3743/4885BBOX1 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.